United Therapeutics (NasdaqGS:UTHR) Q4 2025 Earnings call February 25, 2026 09:00 AM ET Company ParticipantsAshish Varma - Group Internal Audit - AI Initiatives ManagerDewey Steadman - Head of Investor RelationsLeigh Peterson - EVP of Product Development and XenotransplantationMartine Rothblatt - Chairperson and CEOMichael Benkowitz - President and COOConference Call ParticipantsJoseph Thome - Managing Director and Senior Research AnalystRoanna Ruiz - Senior Research AnalystRoger Song - Senior Equity Resear ...

United Therapeutics (NasdaqGS:UTHR) Q4 2025 Earnings call February 25, 2026 09:00 AM ET Company ParticipantsAshish Varma - Group Internal Audit - AI Initiatives ManagerDewey Steadman - Head of Investor RelationsLeigh Peterson - EVP of Product Development and XenotransplantationMartine Rothblatt - Chairperson and CEOMichael Benkowitz - President and COOConference Call ParticipantsJoseph Thome - Managing Director and Senior Research AnalystRoanna Ruiz - Senior Research AnalystRoger Song - Senior Equity Resear ...

United Therapeutics (NasdaqGS:UTHR) Q4 2025 Earnings call February 25, 2026 09:00 AM ET Speaker5Please also know today's event is being recorded. At this time, I'd like to turn the webcast over to Dewey Steadman, Investor Relations Manager at United Therapeutics.Speaker1Thank you, Jamie. Good morning. It is my pleasure to welcome you to the United Therapeutics Corporation 4th quarter 2025 corporate update webcast. Remarks today will include forward-looking statements representing our expectations or beliefs ...